ReutersPfizer and BioNTech launch trial of Omicron-targeted COVID vaccineJan 25, 2022Michael Erman & Ludwig BurgerBy Michael Erman & Ludwig Burgermore_vert
BBC.comPfizer and BioNTech start trials of new Omicron-specific jabJan 25, 2022Philippa RoxbyBy Philippa Roxbymore_vert
Business InsiderCDC charts show hospitalization rates for unvaxxed, 2 doses, 3 dosesJan 28, 2022Marianne GuenotBy Marianne Guenotmore_vert
ReutersModerna starts trial for Omicron-specific booster shotJan 26, 2022Devika Syamnath, Amruta Khandekar & Sherry Jacob-PhillipsBy Devika Syamnath, Amruta Khandekar & Sherry Jacob-Phillipsmore_vert
STATAs Pfizer and BioNTech begin clinical trial of Omicron-based vaccine, timeline to authorization is unclearJan 25, 2022Matthew HerperBy Matthew Herpermore_vert